B-cell Malignancy research hub

A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies

This study is testing a new medicine called BGB-16673 for people with certain types of B-cell cancers, like lymphoma or chronic leukaemia. It aims to find the right dose and see how well it works and if it's safe. It's an early-stage trial.